J&J Lawsuit Claims Wyeth’s Effexor XR Infringes Patent
This article was originally published in The Pink Sheet Daily
Johnson & Johnson subsidiary Alza files patent infringement suit against Wyeth.
You may also be interested in...
Teva began shipping the generic of Wyeth's antidepressant Aug. 4.
Manufacturing facility concerns likely will derail approval of the oral contraceptive and the antidepressant before the end of the year.
Pfizer's Ibrance still dominates the category but sales slowed in the first quarter, while Novartis’s Kisqali and Lilly's Verzenio both grew double digits.